TKIs are drugs designed to inhibit the enzymatic activity of TKRs. They block the ATP-binding site of the receptor, preventing autophosphorylation and subsequent signaling. Common side effects include fatigue, diarrhea, and skin rashes. Nurses should monitor patients for these side effects and manage them accordingly.
